Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients-Reference-Cited by-同舟云学术

Effect of acute administration of vitamin C on muscle sympathetic activity, cardiac sympathovagal balance, and baroreflex sensitivity in hypertensive patients

Published:2012-06-13 Issue:2 Volume:96 Page:302-308
ISSN:0002-9165
Container-title:The American Journal of Clinical Nutrition
language:en
Short-container-title:

Author:

Bruno Rosa M,Daghini Elena,Ghiadoni Lorenzo,Sudano Isabella,Rugani Ilaria,Varanini Maurizio,Passino Claudio,Emdin Michele,Taddei Stefano

Publisher

Oxford University Press (OUP)

Subject

Nutrition and Dietetics,Medicine (miscellaneous)

Link

http://academic.oup.com/ajcn/article-pdf/96/2/302/23817033/302.pdf

Reference35 articles.

1. Sympathetic predominance in essential hypertension: a study employing spectral analysis of heart rate variability;Guzzetti;J Hypertens,1988

2. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension;Grassi;Hypertension,1998

3. Targeting reactive oxygen species in hypertension;Delles;Antioxid Redox Signal,2008

4. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats;Shokoji;Hypertension,2003

5. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity;Campese;Hypertension,2005

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renal denervation benefits in chronic kidney disease: An updated review;Yemen Journal of Medicine;2024-09-15

2. Ocular Neuromodulation as a Novel Treatment for Retinitis Pigmentosa: Identifying Rod Responders and Predictors of Visual Improvement;2024-06-27

3. Daily Considerations to Reduce the Risk of Cardiovascular Diseases;Advances in Medical Diagnosis, Treatment, and Care;2024-06-14

4. Vitamin C deficiency can lead to pulmonary hypertension: a systematic review of case reports;BMC Pulmonary Medicine;2024-03-19

5. Potential for reducing resting sympathetic nerve activity with new classes of glucose-lowering drugs in heart failure with preserved ejection fraction;Clinical Autonomic Research;2024-01-29